Abstract

To evaluate the safety and performance of a crosslinked thiolated carboxymethyl hyaluronic acid liquid-gel (CMHA-S) ocular bandage gel in accelerating reepithelialization of corneal defects created for photorefractive keratectomy (PRK). Three community-based clinical research sites. Prospective case series. Patients scheduled for bilateral PRK had both eyes randomized immediately after PRK to Group 1 (ocular bandage gel 4 times a day for 14days and bandage contact lens), Group 2 (ocular bandage gel 4 times a day for 14days), or Group 3 (control; bandage contact lens and artificial tears 4 times a day for 14days). Patients received a 9.0mm epithelial defect for PRK and were followed through 28days postoperatively. Safety assessments included adverse events, vision, pain, slitlamp, intraocular pressure, and fundus examinations. The primary performance endpoint was time to corneal reepithelialization after PRK. The study comprised 39 patients. The ocular bandage gel was well tolerated. The time to reepithelialization was 3days for 54.5%, 80.0%, and 45.5% of patients in Group1, Group 2, and Group 3, respectively. Compared with measurements in the control group, the mean horizontal andvertical defect lengths in Group 2 (ocular bandage gelalone) were 36.9% and 29.0% smaller, respectively, by 1day. Crosslinked hyaluronic acid showed the ability to quickly reepithelialize the cornea and may promise a well-tolerated and effective therapy for ocular wound care after trauma, disease, or surgery.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.